Endoplasmic reticulum stress causes thyroglobulin retention in this organelle and triggers activation of nuclear factor-κB via tumor necrosis factor receptor-associated factor 2

被引:37
作者
Leonardi, A
Vito, P
Mauro, C
Pacifico, F
Ulianich, L
Consiglio, E
Formisano, S
Di Jeso, B
机构
[1] Univ Lecce, Fac Sci MFN, Dipartimento Sci & Technol Biol Ambientali, Lab Patol Gen, I-73100 Lecce, Italy
[2] Univ Naples Federico II, Dipartimento Biol & Patol Cellulare & Mol, I-80100 Naples, Italy
[3] Univ Naples Federico II, BioGem Consortium, I-80100 Naples, Italy
[4] Univ Naples Federico II, Ctr Endocrinol & Oncol Sperimentale, I-80100 Naples, Italy
关键词
D O I
10.1210/en.143.6.2169
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Perturbing the endoplasmic reticulum. homeostasis of thyroid cell lines with thapsigargin, a specific inhibitor of the sarco-endoplasmic reticulum. Ca2+ adenosine triphosphatases, and tunicamycin, an inhibitor of the N-linked glycosylation, blocked Tg in the endoplasmic reticulum. This event was signaled outside the endoplasmic reticulum and resulted in activation of the c-Jun N-terminal kinase (JNR)/stress-activated protein kinase and nuclear factor-kappaB (NF-kappaB) stress response pathways. Activation of the JNK/stress-activated protein kinase signaling pathway was assessed by measuring the amount of phospho-JNK and the activity of JNK by kinase assays. Activation of the NF-kappaB signaling pathway was assessed by measuring the level of inhibitory subunit IkappaBalpha, DNA binding, and transcriptional activity of NF-kappaB. Cycloheximide treatment, at a dose able to profoundly inhibit protein synthesis in FRTL-5 cells, obliterated the decrease in the level of the inhibitory subunit IkappaBalpha produced by thapsigargin and tunicamycin. Therefore, protein synthesis was required to generate a signal from stressed endoplasmic reticulum. This substantiates the hypothesis that endoplasmic reticulum retention of newly synthesized Tg and other cargo (secretory and membrane) proteins functions upstream of signal activation. Dominant negative TNT receptor-associated factor 2 (TRAF2) inhibited activation of NF-kappaB, which was also inhibited in embryonic fibroblasts derived from TRAF2(-/-) mice, respect to their normal counterpart. These data extend the recent demonstration that TRAF2 mediated JNK activation in response to endoplasmic reticulum stress and strongly strengthened the idea that endogenous stress signals initiated in the endoplasmic reticulum proceed by a pathway similar to that initiated by plasma membrane receptors in response to extracellular signals.
引用
收藏
页码:2169 / 2177
页数:9
相关论文
共 45 条
[1]  
Ambesi-Impiombato F.S., 1986, US Patent, Patent No. [4,608,341, 4608341]
[2]   Tumor necrosis factor receptor-associated factors (TRAFs) - a family of adaptor proteins that regulates life and death [J].
Arch, RH ;
Gedrich, RW ;
Thompson, CB .
GENES & DEVELOPMENT, 1998, 12 (18) :2821-2830
[3]   Mechanism of endoplasmic reticulum retention of mutant vasopressin precursor caused by a signal peptide truncation associated with diabetes insipidus [J].
Beuret, N ;
Rutishauser, J ;
Bider, MD ;
Spiess, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (27) :18965-18972
[4]   SUBTLE STRUCTURAL ALTERATIONS IN THE CHAINS OF TYPE-I PROCOLLAGEN PRODUCE OSTEOGENESIS IMPERFECTA TYPE-II [J].
BONADIO, J ;
BYERS, PH .
NATURE, 1985, 316 (6026) :363-366
[5]  
Brostrom CO, 1998, PROG NUCLEIC ACID RE, V58, P79
[6]  
De Vijlder Jan J. M., 1996, P749
[7]   Demonstration of a Ca2+ requirement for thyroglobulin dimerization and export to the golgi complex [J].
Di Jeso, B ;
Pereira, R ;
Consiglio, E ;
Formisano, S ;
Satrustegui, J ;
Sandoval, IV .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1998, 252 (03) :583-590
[8]  
DIJESO B, 1992, J BIOL CHEM, V267, P1938
[9]   Protein translation and folding are coupled by an endoplasmic-reticulum-resident kinase [J].
Harding, HP ;
Zhang, YH ;
Ron, D .
NATURE, 1999, 397 (6716) :271-274
[10]   Two novel cysteine substitutions (C1263R and C1995S) of thyroglobulin cause a defect in intracellular transport of thyroglobulin in patients with congenital goiter and the variant type of adenomatous goiter [J].
Hishinuma, A ;
Takamatsu, J ;
Ohyama, Y ;
Yokozawa, T ;
Kanno, Y ;
Kuma, K ;
Yoshida, S ;
Matsuura, N ;
Ieiri, T .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (04) :1438-1444